estradiol
发表于 2025-3-21 18:42:04
书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0158692<br><br> <br><br>书目名称Antitrust in Pharmaceutical Markets & Geographical Rules of Origin读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0158692<br><br> <br><br>
folliculitis
发表于 2025-3-21 22:57:08
Austrial Act 2005 (hereafter referred to as “Cartel Act”) and the Austrian Competition Act 2002 (hereafter referred to as “Competition Act”). The Competition Act complements the Cartel Act and contains rules on the Federal Competition Authority (., hereafter referred to as FCA), its tasks, and some procedu
严厉谴责
发表于 2025-3-22 02:51:57
http://reply.papertrans.cn/16/1587/158692/158692_3.png
新星
发表于 2025-3-22 06:30:12
http://reply.papertrans.cn/16/1587/158692/158692_4.png
Conducive
发表于 2025-3-22 09:42:31
Hungaryrian Competition Authority. However, certain provisions of Hungarian pharmaceutical regulation are relevant from a competition law viewpoint (e.g. regulation promoting generic entry and prescribing a domestic supply obligation). The cases investigated by the Hungarian Competition Authority concern b
增长
发表于 2025-3-22 13:16:30
Italyicle 2, on anticompetitive agreements, and Article 3, on abuse of dominant position, of Law 287/90 (the “Italian Antitrust Law” or the IAL), which contain the same principles of Articles 101 and 102 TFEU.
optic-nerve
发表于 2025-3-22 20:18:40
http://reply.papertrans.cn/16/1587/158692/158692_7.png
Acquired
发表于 2025-3-22 22:18:32
Polandtion law. We consider the general legislative framework and specific provisions of pharmaceutical law concerning competition law aspects, as well as the enforcement of competition law in the pharmaceutical sector. We also reflect upon the interplay between competition law and intellectual property,
财主
发表于 2025-3-23 04:36:26
Swedenompetition rules or specific sectorial non-competition legislation. Swedish Competition Law enforcement has been, so far, sporadic at best, and has not addressed particularly “sexy” issues such as hardcore cases of refusal to license and pay-for-delay settlement agreements. Instead, the Swedish non-
periodontitis
发表于 2025-3-23 07:43:06
http://reply.papertrans.cn/16/1587/158692/158692_10.png